Science News
from research organizations

Measuring macular pigment offers potential as a biomarker of cognitive health

Date:
August 25, 2015
Source:
IOS Press
Summary:
Researchers are investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health.
Share:
FULL STORY

Ongoing European Research Council-funded research at Waterford Institute of Technology's (WIT) Macular Pigment Research Group (MPRG) is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health.

The Waterford clinical trial research, conducted by a team of 10 researchers and healthcare professionals, investigated two patient groups -- those free of retinal disease but with low macular pigment and those with early age-related macular degeneration.

A series of tests were carried out on the volunteer trial patients at the analytical and vision laboratories in Carriganore House on WIT's West Campus where the MPRG is based. These examined the relationship between serum concentrations of the macular carotenoids lutein and zeaxanthin, macular pigment levels in the eye and cognitive function.

The results showed a significant link between macular pigment levels in the eye and various measures of cognitive performance in both groups of patients, while serum lutein and zeaxanthin levels correlated with cognitive performance on only two tests. When the researchers controlled for variables such as age, gender, diet, and education levels, the correlations between macular pigment and cognitive function remained statistically significant, while the correlations between serum lutein and zeaxanthin and cognitive function were no longer significant.

Prof John Nolan, Principal Investigator at the MPRG and a Fulbright Scholar, Howard Foundation Chair and European Research Council (ERC)-funded Fellow, said: "Given the growing prevalence of Alzheimer's, it is obviously very exciting to be involved in leading-edge research that is opening up new possibilities in terms of detecting patients at most risk of the disease at an earlier stage than has previously been possible.

Dr George Perry, Editor-in-Chief of the Journal of Alzheimer's Disease, commented that the surprising and novel result of this study opens new therapeutic and conceptual insights to benefit patients in the near term.


Story Source:

Materials provided by IOS Press. Note: Content may be edited for style and length.


Journal Reference:

  1. David Kelly et al. Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids. Journal of Alzheimer’s Disease, 2015 DOI: 10.3233/JAD-150199

Cite This Page:

IOS Press. "Measuring macular pigment offers potential as a biomarker of cognitive health." ScienceDaily. ScienceDaily, 25 August 2015. <www.sciencedaily.com/releases/2015/08/150825083748.htm>.
IOS Press. (2015, August 25). Measuring macular pigment offers potential as a biomarker of cognitive health. ScienceDaily. Retrieved May 8, 2017 from www.sciencedaily.com/releases/2015/08/150825083748.htm
IOS Press. "Measuring macular pigment offers potential as a biomarker of cognitive health." ScienceDaily. www.sciencedaily.com/releases/2015/08/150825083748.htm (accessed May 8, 2017).